N/A
N=19
Hearing Aid Quality and Reliability Study
Hearing Loss
Bottom Line
View on ClinicalTrials.gov: NCT04995666 ↗Enrolled (actual)
19
Serious AEs
0.0%
Results posted
May 2023
Primary outcome: Primary: Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 1 — 38; 0 hearing aid devices
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Phonak Audeo hearing aid (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Sonova AG
- Primary completion
- Sep 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 1 |
38; 0 | — |
| PRIMARY Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 45 |
38; 0 | — |
| PRIMARY Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 90 |
35; 2 | — |
Summary
Quality and reliability study of hearing aid. Adults with mild to severe hearing loss will wear hearing aids daily for approximately 3 months.
Eligibility Criteria
Inclusion Criteria
- Adults with mild to moderate severe sensorineural hearing loss
- Adults who were able to incorporate some type of physical activity into their day (i.e walking, excercise, gardening, etc.)
Exclusion Criteria
- Unable or unwilling to wear study devices during a home trial
- Unable or unwilling to come to lab for study visits
Data sourced from ClinicalTrials.gov (NCT04995666). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.